Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 2
This trial is investigating whether the hormone treatment enzalutamide is a useful treatment for women with breast cancer before they have surgery.
It is for women with one of the following
breast cancer that has oestrogen receptors (oestrogen receptor positive)
breast cancer that has androgen receptors, but doesn’t have receptors for the hormones progesterone and oestrogen, or for the protein HER2 (triple negative breast cancer)
Recruitment start: 24 August 2015
Recruitment end: 30 January 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Schmid
Astellas Pharma
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Queen Mary University of London
Last reviewed: 23 February 2018
CRUK internal database number: 13142
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
